EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implementing reverse translational research in psychiatry

Annakarina Mundorf, Sebastian Ocklenburg

Frontiers in Psychiatry · 08.07.2026 · 17

DOI: 10.3389/fpsyt.2026.1864491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 08.07.2026. Verfasst von Annakarina Mundorf und 1 weiteren Autor:innen. Beteiligte Einrichtung: ISM Institute for Systems Medicine and Department of Human Medicine, MSH Medical School Hamburg, Hamburg, Germany. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Animal models play an important role in psychiatric research, but a lack of translational relevance can impair their usefulness. For example, some rodent paradigms, including the forced swim and tail suspension test, have long been employed to study depressive-and anxiety-like behaviors. While widely used, their translational relevance remains limited.Forced swim and tail suspension paradigms, for instance, primarily measure immobility as a proxy for behavioral despair, but this behavior can be influenced by locomotor activity or habituation rather than core depressive features. Importantly, these paradigms are often interpreted within a broader behavioral test battery that includes measures such as locomotor activity or open field exploration to control for such confounds, although this does not fully resolve concerns about their construct validity. Recent work demonstrates that the forced swim test predicts antidepressant efficacy poorly, with only a fraction of compounds showing correspondence with human clinical outcomes 1 . Historically, these assays were developed and validated primarily as pharmacological screening tools for monoaminergic antidepressants, which may further limit their utility for identifying novel mechanisms or treatments acting via non-traditional targets 1 . These limitations create discrepancies between preclinical and clinical outcomes, reducing the predictive power of animal studies and underscoring the need for approaches that better link models with patient-relevant phenomena 2, 3 .The translational gap is amplified by psychiatric heterogeneity: patients with the same DSM diagnosis may differ in symptoms, trajectory, and treatment response, yet preclinical models often reduce disorders to uniform behavioral readouts.One new approach to achieve this is so-called reverse translational research. In translational research, an animal model is created to mimic symptom patterns experienced by human patients with a specific diagnosis. This way basic research on cellular or molecular processes in this disorder can be conducted in the animal model and results from these studies can provide insights into optimizing treatment in human patients. One problem with this approach is that the tasks used to assess symptoms of psychiatric disorders in these animal models are quite different than psychiatric diagnostics with clinical interviews in patients. Reverse translational research addresses this need by inverting the conventional bench-to-bedside approach: animal models and preclinical paradigms inform the design of human experiments, enabling more precise and comparable measures in clinical studies. By translating insights from established animal paradigms to humans, reverse translation enhances construct validity and improves interpretability across species. Importantly, while cross-species approaches are not entirely new (classical conditioning and extinction paradigms have long been successfully implemented in both animals and humans 3,4 ), these approaches were often highly controlled and theory-driven, rather than grounded in ethologically relevant behavior. Reverse translational strategies extend this tradition by focusing more explicitly on naturalistic, species-relevant behaviors and their underlying neurobiological mechanisms.Several recent studies illustrate reverse translational research by adapting well-established animal behavioral paradigms for humans. For example, a virtual reality version of the open field test showed that humans, like rodents, prefer to stay close to walls rather than explore the center. This behavior is enhanced in individuals with agoraphobia or high anxiety sensitivity, demonstrating the relevance of animal-derived measures for human anxiety 5 .Similarly, a mixed-reality version of the rodent elevated plus maze revealed comparable avoidance of open arms and modulation of behavior by anxiety levels and pharmacological interventions 6 . More broadly, ethologically informed animal paradigms can provide the conceptual and methodological foundation for designing human experiments and generating cross-species benchmark data 7,2 . Comparable cross-species alignment has also been demonstrated in probabilistic learning, affective bias, and effort-based decision-making paradigms 2 , further supporting the generalizability of this approach across psychiatric domains. By emphasizing construct validity and translational relevance, these approaches allow preclinical behavioral tests to meaningfully inform human research, refining our understanding of anxiety and depressive phenotypes and guiding the development of clinically relevant assessments. In this context, construct validity should not be understood as mere surface similarity between animal and human behavior, but rather as the extent to which paradigms capture shared underlying processes or latent constructs that are measurable across species.Beyond depression and anxiety, reverse translational strategies have been applied in other neuropsychiatric contexts. For instance, alcohol use disorder research demonstrates how wellcharacterized rodent paradigms can be translated into human laboratory experiments, clarifying which behavioral readouts correspond to clinical constructs such as compulsive consumption or reward sensitivity 3 . By systematically aligning preclinical and clinical endpoints, these approaches facilitate the design of human studies directly informed by animal behavior and enhance predictive validity. However, in psychiatric research, these strategies remain largely underutilized, often restricted to isolated studies or theoretical comparisons of which animal tasks correspond to specific human endpoints.The integration of clinical insights, preclinical experimentation, and innovative technologies fosters a dynamic, iterative research pipeline. Findings from animal models generate mechanistic hypotheses that can be tested in humans, creating a feedback loop in which patient data inform model refinement. Despite this potential, systematic implementation across psychiatric disorders is rare, and the full power of animal-to-human reverse translation has yet to be realized. This bidirectional flow not only strengthens the translational validity of preclinical research but also supports precision psychiatry by enabling the development of interventions tailored to subpopulations defined by cognitive, neurobiological, or molecular profiles 8 . By aligning specific behavioral readouts across species, reverse translational approaches can help link clinically observed deficits, such as impairments in attention or social cognition, to underlying neurobiological mechanisms 9,10 . Such cross-species correspondence may improve the characterization of disorder-related heterogeneity and, in conjunction with translational models of neurobehavioral phenotypes, inform the development of more targeted and effective interventions. Expanding reverse translational research in psychiatry is therefore essential to guide therapeutic innovation, and ultimately to improve patient outcomes.Embracing reverse translational research promises to overcome longstanding barriers to translating preclinical findings into clinical care. By systematically aligning animal paradigms with patient-relevant endpoints, integrating novel technologies, and focusing on mechanistically informative phenotypes, psychiatry can develop interventions that are both predictive and personalized. To achieve this, animal paradigms should ideally fulfill several criteria, including ethological relevance, robustness and reproducibility, clear quantifiability of behavior, and the ability to capture processes that can be operationalized in both animals and humans. Paradigms that meet these criteria are particularly well-suited for reverse translation, whereas others may be more difficult to adapt across species. This framework moves the field beyond traditional symptom-based modeling toward a more nuanced, mechanistically grounded understanding of psychiatric disorders, enhancing scientific insight and therapeutic potential.

Schlagwörter

Stichwörter der Autor:innen

addiction disordersanimal modelsanxiety disordersbehavior & cognitionmood disorderreverse translational research

Autor:innen und Institutionen

  • ISM Institute for Systems Medicine and Department of Human Medicine, MSH Medical School Hamburg, Hamburg, Germany.
  • ICAN Institute for Cognitive and Affective Neuroscience and Department of Psychology, MSH Medical School Hamburg, Hamburg, Germany.
  • Biopsychology, Institute of Cognitive Neuroscience, Faculty of Psychology, Ruhr University Bochum, Bochum, Germany.

Zitieren

APA

Mundorf, A., & Ocklenburg, S. (2026). Implementing reverse translational research in psychiatry. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1864491

Vancouver

Mundorf A, Ocklenburg S. Implementing reverse translational research in psychiatry. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1864491

BibTeX
@article{Mundorf2026,
  author = {Mundorf, Annakarina and Ocklenburg, Sebastian},
  title = {Implementing reverse translational research in psychiatry},
  journal = {Frontiers in Psychiatry},
  year = {2026},
  volume = {17},
  doi = {10.3389/fpsyt.2026.1864491}
}
Kostenlos starten →